FDA Investigator Jee Chung, PhD
Jee Chung, PhD has inspections in 1 countries as of 13 Oct 2023. Jee Chung, PhD has collaborated with a combinined 3115 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aimee Cunningham, PhD,
Alice S Tsao,
Amalia C Himaya,
Amalia Himaya,
Amy Devlin, PhD,
Anastasia G Lolas,
Andrea Siegel, PhD,
Anissa M Cheung,
Anita Narula, PhD,
Anjali Shukla, PhD,
Arie C Menachem,
Ashutosh Rao, PhD,
Barry Cherney, PhD,
Bichsa T Nguyen,
Bichsa T Tran,
Bo Chi, PhD,
Bonita S Chester,
Brenda P King,
Brentley S Collins,
Brently S Collins,
Brien C Fox,
Brooke K Higgins,
Burnell M Henry,
Carla J Lundi,
Caryn M Mcnab,
Chaltu N Wakijra,
Charles L Zhou,
Charles R Cote, RIC,
Cheron M Portee,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christina V Santos,
Christopher Downey, PhD,
Como,
Constance Lrichard Math,
Daniel W Cline,
Davinna Ligons, PhD,
Dawn M Braswell,
Devaughn Edwards,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Donald C Obenhuber, PhD,
Donna Ltartaglino Besone,
Ekaterina Allen,
Ellen P Madigan,
Frances Namuswe, PhD,
Gene D Arcy,
Gregory R Brinsley,
Gunther Bockhoudt,
Gunther Boekhoudt, PhD,
Haley H Seymour,
Haley Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Iris C Macinnes,
Ivan E Reyes,
Jacek Cieslak, PhD,
Jacob W Reynolds,
James R Fleckenstein,
Janis R Armedoriz,
Jason F Chancey,
Jeffrey P Raimondi,
Jeffry A Bernhardt,
Jennifer Gogley,
Jennifer M Gogley,
Jennifer Swisher, PhD,
Joel D Hosteos,
Joel D Hustedt,
Joel Welch, PhD,
John R Myung,
Jonathan W Chapman,
Joyce A Rockwell,
Julie D Bringger,
Jun Park, PhD,
Justin A Boyd,
Justine M Corson,
Ka L Wong,
Kalavati Suvarna, PhD,
Kara A Scheibner, PhD,
Kathleen R Jones, PhD,
Kathy Lee,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kim Lthomas Cruse,
Laura Fontan, MS,
LCDR Debra Emerson,
Leonard H Lavi,
Leopold Kong, PhD,
Leslie Arivera Rosado, PhD,
Lori B Wikstrom,
LT Richard A Lyght,
Madushini Dharmasena, PhD,
Marcia Britt Williams,
Marcus F Yambot,
Maria Gutierrez Lugo, PhD,
Marie A Fadden,
Martha T Olone,
Mary E Farbman, PhD,
Mary Kaulee,
Maxwell Van Tassell, PhD,
Maxyne T Lam,
Megan A Haggerty,
Michael Shanks, MS,
Michelle A Marsh,
Michelle M Noe,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Monique C Lo,
Nailing Zhang,
Nebil A Oumer,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Paula A Trost,
Penny H Mccarver,
Peter S Diak,
Prabhu P Raju,
Priscilla M Pastrana,
Rachel C Harrington,
Rebecca Rodriguez,
Richard H Penta,
Richard Ledwidge (nmi), PhD,
Richard W Thornton,
Richmond K Yip,
Robert D Tollefsen,
Robert Darius,
Roger F Zabinski,
Ronald L Koller,
Ronda Lebland,
Sandra A Hughes,
Sarah Arden,
Scott R Nichols, PhD,
Sean R Marcsisin,
Seneca D Toms,
Seth A Mailhot,
Shadia Zaman, PhD,
Sidney B Priesmeyer,
Simon Williams, PhD,
Sonia R Peterson,
Sonya M Edmonds,
Stacey S Degarmo,
Stanley Au,
Steven E Bowen, PhD,
Steven Fong, MS, PhD,
Taichun Qin, PhD,
Tenzin Jangchup,
Terri L Dodds,
Thao T Kwan,
Thao Tran,
Thao X Tran,
Thuy T Nguyen, LCDR,
Thuy Y Nguyen,
Uttaniti Limchumroon (Tom),
Veronica Fuentes, MS,
Victor J Gangi,
Walter Lange,
Wayne E Seifert,
Xiaoshi Wang,
Xiaoxiao Pan, PhD,
Xuhong Li,
Yanming An, PhD,
Ying Xin Fan, PhD,
Yuan Chia Kuo,
Yumi J Hiramine,
Yun Wu, PhD,
Yvonne C Wilkes,
Zhenzhen Liu, PhD,
Zhihao Qiu (Peter), PhD
Jee Chung, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| May, 2017 | FDA 483 | Amgen, Inc - Form 483, 2017-05-16 |
| January, 2019 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2019-01-18 |
| February, 2023 | FDA 483 | FUJIFILM Diosynth Biotechnologies U.S.A., Inc - Form 483, 2023-02-10 |
| January, 2019 | EIR | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - EIR, 2019-01-18 |
| January, 2014 | FDA 483 | Kingchem Laboratories Inc. - Form 483, 2014-01-10 |
| April, 2013 | FDA 483 | Human Genome Sciences, Inc. - Form 483, 2013-04-26 |
| January, 2019 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2019-01-17 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more